Poor bioavailability is a major reason for compounds to fail in preclinical development. Due to the complex nature of a multitude of existing as well as newly discovered active ingredients, solubility and bioavailability problems are inherent in the pharmaceutical industry causing major delays in drug development...
See more at: http://drug-dev.com/Main/Back-Issues/SPECIAL-FEATURE-Bioavailability-Solubility-A-Deman-875.aspx#sthash.ah8PQxq2.dpuf
Bioavailability & Solubility: A Demand for Enhanced Technologies & Materials is Spurring Innovation
Drug Development & Delivery
Issue: March 2015, Posted Date: 3/3/2015
Issue: March 2015, Posted Date: 3/3/2015